Transgenomic, Inc. Announces European Distribution Agreement With A. Menarini Diagnostics for its WAVE® System and SURVEYOR® Kits
OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTC/BB: TBIO) and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic’s SURVEYOR® Scan and WAVE® MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.